Vendor, South San Francisco, CA
Denali Therapeutics Inc.
UEI WPDGJCK93HY6, CAGE 81T85
1 award and $0 obligated between May 21, 2026 and May 21, 2026, 100% under full and open competition, against 999.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
Hear when Denali Therapeutics Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Denali Therapeutics Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling pharmaceutical preparation manufacturing to Department of Veterans Affairs, by dollars.
| Mckesson CorporationIrving, TX | $31,474,628,214 |
| Exelan Pharmaceuticals Inc.Boca Raton, FL | $175,193,835 |
| Progenics Pharmaceuticals Inc.North Billerica, MA | $97,174,444 |
| Cardinal Health 414, LLCDublin, OH | $76,366,453 |
| Novartis Pharmaceuticals CorporationEast Hanover, NJ | $57,468,364 |
| Sofie Co.Dulles, VA | $25,337,798 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Denali Therapeutics, Inc. 12/01/2026 - 11/30/2031
Department of Veterans Affairs, Nac Federal Supply Schedule
Award noticeNAICS 325412Anywhere in the US3F79727D0016Awarded to Denali Therapeutics Inc. for $600,000
Posted Nov 53 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36F79726D047EMay 21, 2026, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Interim Agreement Under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related ProductsNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards